CMS Recalculation of Medicare Advantage Ratings Signals Broader Implications from Clover Health Victory
A recent federal court decision in favor of Clover Health has quickly evolved from an insurer-specific dispute into one of the most significant Medicare Advantage (“MA”) regulatory developments in recent years. On May 27, 2026, the U.S. District Court for the Southern District of Georgia held that CMS improperly calculated Clover’s 2026 Star Rating and ordered the agency to set aside and recalculate the rating. The court held that CMS…

